Safety and Immunomodulatory Effects of Three Probiotic Strains Isolated from the Feces of Breast-Fed Infants in Healthy Adults: SETOPROB Study

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Plaza Diaz, Julio ^a   Gomez Llorente, Carolina ^a   Campaña Martin, Laura ^a   Matencio, Esther ^b   Ortuño, Inmaculada ^b   Martínez Silla, Rosario ^b   Gomez Gallego, Carlos ^c   Periago, Maria Jesús ^c   Ros, Gaspar ^c   Chenoll, Empar ^d   Genovés, Salvador ^d   Casinos, Beatriz ^d   Silva, Ángela ^d   Corella, Dolores ^e,f   Portolés, Olga ^e,f   Romero, Fernando ^b   Ramón, Daniel ^d   Perez de la Cruz, Antonio ^g   Gil, Angel ^a   Fontana, Luis ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Hero Spain SA   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f Instituto de Salud Carlos III   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; PLACEBO; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABNORMAL SENSATION; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIFIDOBACTERIUM BREVE; BORBORYGMUS; BREAST FEEDING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEFECATION URGENCY; DOUBLE BLIND PROCEDURE; DRUG DETERMINATION; DRUG EFFECT; DRUG ISOLATION; DRUG SAFETY; DRUG TOLERANCE; DYSPEPSIA; ENTEROPATHY; ERUCTATION; FECES ANALYSIS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HARD FECES; HEARTBURN; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INDIGESTION; INFANT; INTESTINE MUCOSA; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; LEUKOCYTE COUNT; LOOSE FECES; MALE; MULTICENTER STUDY; NAUSEA AND VOMITING; NONHUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POPULATION ABUNDANCE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMACH DISEASE; STRAIN DIFFERENCE;

ADULT; BIFIDOBACTERIUM; BREAST FEEDING; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; INTERLEUKIN-4; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; PROBIOTICS;

EID: 84886620699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078111     Document Type: Article

References (33)

1. World Health Organization and Food & Agriculture Organization (2002) Guidelines for the Evaluation of Probiotics in Food. Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada. Retrieved onpublished at whilst December year 1111 from ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
2. Fontana L, Bermudez-Brito M, Plaza-Diaz J, Muñoz-Quezada S, Gil A, (2013) Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr 109: S35-S50. doi:10.1017/S0007114512004011. PubMed: 23360880.
3. Guarner F, Malagelada JR, (2003) Gut flora in health and disease. Lancet. 361: 512-519. doi:10.1016/S0140-6736(03)12489-0. PubMed: 12583961.
4. Gourbeyre P, Denery S, Bodinier M, (2011) Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol 89: 685-695. doi:10.1189/jlb.1109753. PubMed: 21233408.
5. Macpherson AJ, Harris NL, (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4: 478-485. doi:10.1038/nri1373. PubMed: 15173836.
6. Frick JS, Schenk K, Quitadamo M, Kahl F, Köberle M, et al. (2007) Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. Inflamm Bowel Dis 13: 83-90. doi:10.1002/ibd.20009. PubMed: 17206643.
7. Vankerckhoven V, Huys G, Vancanneyt M, Vael C, Klare I, et al. (2008) Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE Project. Trends Food Sci Technol 19: 102-114. doi:10.1016/j.tifs.2007.07.013.
8. Collins JK, Thornton G, Sullivan GO, (1998) Selection of probiotic strains for human application. Int Dairy J 8: 487-490. doi:10.1016/S0958-6946(98)00073-9.
9. Ouwehand AC, Salminen S, Isolauri E, (2002) Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 82: 279-289. doi:10.1023/A:1020620607611. PubMed: 12369194.
10. Muñoz-Quezada S, Chenoll E, Vieites JM, Genovés S, Maldonado J, et al. (2013) Isolation, identification and characterisation of three novel probiotic strains (Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036) from the faeces of exclusively breast-fed infants. Br J Nutr 109: S51-S62. doi:10.1017/S0007114512005211. PubMed: 23360881.
11. Rios S, (1967) Métodos estadísticos. Madrid, Spain: Ediciones del Castillo.
12. Wind RD, Tolboom H, Klare I, Huys G, Knol J, (2010) Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers. Br J Nutr 104: 1806-1816. doi:10.1017/S0007114510002746. PubMed: 20691131.
13. Svedlund J, Sjödin I, Dotevall G, (1988) GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33: 129-134. doi:10.1007/BF01535722. PubMed: 3123181.
14. Whelan K, Judd PA, Taylor MA, (2004) Assessment of fecal output in patients receiving enteral tube feeding: validation of a novel chart. Eur J Clin Nutr 58: 1030-1037. doi:10.1038/sj.ejcn.1601927. PubMed: 15220945.
15. Van Aerde J, Alarcon P, Lam W, (2003) Tolerance and safety of energy-dense enteral formulae for young children. Int Pediatr 18: 95-99.
16. Fallani M, Young D, Scott J, Norin E, Amarri S, et al. (2010) Intestinal microbiota of 6-weeks-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr 51: 77-84. doi:10.1097/MPG.0b013e3181d1b11e. PubMed: 20479681.
17. Gomez-Llorente C, Plaza-Diaz J, Aguilera M, Muñoz-Quezada S, Bermudez-Brito et al,. (2013) Three main factors define changes in fecal microbiota associated with feeding modality in infants. J Pediatr Gastroenterol Nutr (In press).
18. Langendijk PS, Schut F, Jansen GL, Raangs GC, Kamphuis GR, et al. (1995) Quantitative fluorescent in situ hybridization of Bifidobacterium spp. with genus specific 16S ribosomal-RNA targeted probes and its application in fecal samples. Appl Environ Microbiol 61: 3069-3075. PubMed: 7487040.
19. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer KH, (1996) Application of a suite of 16S rRNA specific oligonucleotide probes designed to investigate bacteria of the phylum Cytophaga-flavobacter-bacteroides in the natural environment. Microbiology (Reading, Engl.) 142: 1097-1106.
20. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, et al. (2000) Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 66: 2263-2266. doi:10.1128/AEM.66.5.2263-2266.2000. PubMed: 10788414.
21. Franks AH, Harmsen HJM, Raangs GC, Jansen GJ, Schut F, et al. (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64: 3336-3345. PubMed: 9726880.
22. Harmsen HJM, Elfferich P, Schut F, Welling GW, (1999) A 16S rRNA-targeted probe for detection of Lactobacilli and Enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 11: 3-12. doi:10.1080/089106099435862.
23. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, et al. (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30: 61-67. doi:10.1097/00005176-200001001-00010. PubMed: 10630441.
24. Lay C, Sutren M, Rochet V, Saunier K, Doré J, et al. (2005) Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota. Environ Microbiol 7: 933-946. doi:10.1111/j.1462-2920.2005.00763.x. PubMed: 15946290.
25. Fallani M, Rigottier-Gois L, Aguilera M, Bridonneau C, Collignon A, et al. (2006) Clostridium difficile and Clostridium perfringens species detected in infant faecal microbiota using 16S rRNA targeted probes. J Microbiol Methods 67: 150-116. doi:10.1016/j.mimet.2006.03.010. PubMed: 16647148.
26. Scardovi V, (1986) Genus Bifidobacterium. In: Sneath PHA, Mair NS, Sharpe ME, eds. Bergey's Manual of Systematic. J Bacteriol: pp. 1418-1434.
27. Gorbach SL, Chang TW, Goldin B, (1987) Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet. 2: 1519. PubMed: 2892070.
28. Lawrence SJ, Korzenik JR, Mundy LM, (2005) Probiotics for recurrent Clostridium difficile disease. J Med Microbiol 54: 905-906. doi:10.1099/jmm.0.46096-0. PubMed: 16091446.
29. Na X, Kelly C, (2011) Probiotics in clostridium difficile Infection. J Clin Gastroenterol 45: S154-S158. doi:10.1097/MCG.0b013e31822ec787. PubMed: 21992956.
30. Mantis NJ, Rol N, Corthésy B, (2011) Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4: 603-611. doi:10.1038/mi.2011.41. PubMed: 21975936.
31. Mäkeläinen H, Tahvonen R, Salminen S, Ouwehand AC, (2003) In vivo safety assessment of two Bifidobacterium longum strains. Microbiol Immunol 47: 911-914. PubMed: 14695440.
32. Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, et al. (2012) Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activation. PLOS ONE 7: e43197. doi:10.1371/journal.pone.0043197. PubMed: 22905233.
33. Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, et al. (2013) Cell-Free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-Inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLOS ONE 8: e59370. doi:10.1371/journal.pone.0059370. PubMed: 23555025.